Detalhe da pesquisa
1.
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
Biochim Biophys Acta
; 1863(3): 438-448, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26278055
2.
Effects of mutations in Wnt/ß-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
Biochim Biophys Acta
; 1863(12): 2942-2976, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612668
3.
The therapeutic potential of mTOR inhibitors in breast cancer.
Br J Clin Pharmacol
; 82(5): 1189-1212, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059645
4.
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
Biomolecules
; 12(2)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35204775
5.
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression.
Cells
; 11(14)2022 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35883598
6.
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53.
Adv Biol Regul
; 83: 100840, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34866036
7.
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.
Cells
; 11(5)2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269416
8.
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.
Aging (Albany NY)
; 14(8): 3365-3386, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477123
9.
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
J Cell Physiol
; 226(11): 2762-81, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21302297
10.
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53.
Adv Biol Regul
; 79: 100780, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451973
11.
GSK-3ß Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Cells
; 10(4)2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917370
12.
Emerging MEK inhibitors.
Expert Opin Emerg Drugs
; 15(2): 203-23, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20151845
13.
GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells.
Biochim Biophys Acta Mol Cell Res
; 1867(10): 118770, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524999
14.
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling.
Adv Biol Regul
; 78: 100758, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022466
15.
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer.
Cells
; 9(5)2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365809
16.
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.
Aging (Albany NY)
; 12(11): 10194-10210, 2020 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32492656
17.
New landscapes and horizons in hepatocellular carcinoma therapy.
Aging (Albany NY)
; 12(3): 3053-3094, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32018226
18.
Cancer therapy and treatments during COVID-19 era.
Adv Biol Regul
; 77: 100739, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773105
19.
Abilities of ß-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells.
Adv Biol Regul
; 75: 100672, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685431
20.
Emerging Raf inhibitors.
Expert Opin Emerg Drugs
; 14(4): 633-48, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19715444